Letrozole Clinical Trials in Urbana, IL
As of October 2026, 4 paid clinical trials are testing Letrozole in Urbana, Illinois. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
4 clinical trials testing Letrozole
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
Top Research Study Locations in Urbana
Researchers run research studies in Urbana, IL at 23 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Carle Cancer Center | Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 109 |
| The Carle Foundation Hospital | Malignant Solid Neoplasm, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | 21 |
| Carle Foundation Hospital | ARDS (Acute Respiratory Distress Syndrome), Coronary Artery Disease, Gynecologic Procedures | 7 |
| Carle Cancer Institute | Carcinoma, Non-Small Cell Lung, Endometrial Cancer | 2 |
| Carle Health | Alopecia, Breast Cancer, Chemotherapy-induced Alopecia | 2 |
| Freer Hall - University of Illinois | Control Condition, Glucose Metabolism, Obese Patients (BMI ≥ 30 kg/m²) | 2 |
| University of Illinois Urbana-Champaign | Adults, Cognitive Change, EEG | 2 |
| University of Illinois at Urbana-Champaign | Aging, Cognitive Change, Diet, Healthy | 2 |
| Louise Freer Hall | Isotope Labeling, Muscle Health, Muscle Protein Synthesis | 1 |
| Beckman Institute Biomedical Imaging Centre | Tinnitus, Tinnitus Aggravated, Tinnitus, Subjective | 1 |
| Bevier Hall; University of Illinois at Urbana Champaign | Alcohol Drinking, Breastfeeding, Ethanol Intoxication | 1 |
| Carle Cancer Center NCI Community Oncology Research Program | Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 | 1 |
| Carle Foundation Cancer Institute-Urbana | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 1 |
| Carle Foundation Hosp | Lumbar Spinal Stenosis | 1 |
| Carle Foundation Hospital d/b/a Carle Cancer Center | Breast Neoplasms | 1 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Disability Participation and Quality of Life (DPQOL) Laboratory | Multiple Sclerosis, Spinal Cord Injuries (SCI) | 1 |
| Local Institution - 0423 | Non-Small Cell Lung Cancer (NSCLC) | 1 |
| OSF Heart of Mary Medical Center | Lumbar Spinal Stenosis | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
| University of Illinois | Tick Bites | 1 |
| University of Illinois Extension | Relational Problems, Relationships, Marital | 1 |
| University of Illinois at Urbana Champaign | Sleeve Gastrectomy | 1 |
Active & Upcoming Studies in Urbana (2026)
Recruiting trials in Urbana grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (104 active studies)
- Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial · Phase 3 · National Cancer Institute (NCI)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Neurology & pain (6 active studies)
- Optimal Targeted High-definition Transcranial Direct Current Stimulation for Reducing Post-stroke Upper Limb Motor Impairments · Carle Foundation Hospital
- Pain Management for In-Office Gynecologic Procedures Using a Risk-Stratification Pain Calculator · Carle Foundation Hospital
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (2 active studies)
- Exercise and Protein Efficiency in T2D · University of Illinois at Urbana-Champaign
- Optimized Tailored Interventions in Metabolic and Lifestyle Outcomes (OPTIMAL) · University of Illinois at Urbana-Champaign
Cardiovascular (1 active study)
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
Common conditions studied in Urbana
- Malignant Solid Neoplasm (7 active studies)
- Breast Cancer (6 active studies)
- Stage IV Lung Cancer AJCC v8 (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Stage IVB Prostate Cancer AJCC v8 (5 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
Leading research sponsors in Urbana
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- University of Illinois at Urbana-Champaign
Frequently asked questions
How many paid clinical trials are currently recruiting in Urbana?
There are approximately 142 recruiting clinical trials in Urbana, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Urbana pay participants?
Most recruiting trials in Urbana compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Urbana?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Urbana?
The most common conditions under active study in Urbana include Malignant Solid Neoplasm (7), Breast Cancer (6), Stage IV Lung Cancer AJCC v8 (6), Anatomic Stage II Breast Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Urbana?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Urbana on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Urbana?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Urbana?
Recruiting research sites in Urbana include Carle Cancer Center, The Carle Foundation Hospital, Carle Foundation Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Urbana right now?
The largest active categories in Urbana are Cancer & tumors (104), Neurology & pain (6), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.